Dupixent is already funded in adults in Scotland ... the first topical treatment specifically approved for chronic hand eczema (CHE). Join the conversation, on Tuesday 28th January @ 10 am ET ...

It can affect different areas of your body, including your hands ... are: Dupixent (dupilumab) and Adbry (tralokinumab) are FDA-approved biologic therapies for those with severe eczema that ...

Sanofi’s Dupixent has shown there is a market for biologic drugs to treat eczema, and now Spain’s ... the drug came into the hands of Genentech through an acquisition in 2007.

1. Dupixent (dupilumab) for chronic obstructive pulmonary disease: The monoclonal antibody, already approved for eczema, asthma and long-term sinus congestion with nasal polyps, became the first ...